SEC Form 4 · accession 0001179110-16-027516
OMNICELL, INC. · OMCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin Gene Seim
Officer — EVP, Global A & M Adherence
Period of report
Jul 6, 2016
Accepted (ET)
Jul 7, 2016 · 2:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000926326
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 6, 2016 | S | 5,302 | $34.7489 | D | 50,118 | D | |
| Common Stock | holding | — | — | — | 55,420 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2The price reported in Column 4 is a weighted average price. These shares were sold between $34.16 to $35.05. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote